Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
Domain-

TANC2 TRPC3 LRRK2 ANKS1B ASAP2 NFKBIE ANKRD52 SHANK1 TRPC7 SLF1 ANK1 UACA ANKRD26 ANKRD50 SHANK3 KRIT1

2.77e-07248252161.25.40.20
DomainAnkyrin_rpt-contain_dom

TANC2 TRPC3 LRRK2 ANKS1B ASAP2 NFKBIE ANKRD52 SHANK1 TRPC7 SLF1 ANK1 UACA ANKRD26 ANKRD50 SHANK3 KRIT1

3.82e-0725425216IPR020683
DomainAnkyrin_rpt

TANC2 TRPC3 LRRK2 ANKS1B ASAP2 NFKBIE ANKRD52 SHANK1 TRPC7 SLF1 ANK1 UACA ANKRD26 ANKRD50 SHANK3 KRIT1

5.79e-0726225216IPR002110
DomainAnk_2

TANC2 TRPC3 ANKS1B ASAP2 NFKBIE ANKRD52 SHANK1 TRPC7 SLF1 ANK1 UACA ANKRD26 ANKRD50 SHANK3

1.40e-0621525214PF12796
DomainANK

TANC2 TRPC3 ANKS1B ASAP2 NFKBIE ANKRD52 SHANK1 TRPC7 SLF1 ANK1 UACA ANKRD26 ANKRD50 SHANK3 KRIT1

1.72e-0625125215SM00248
DomainANK_REPEAT

TANC2 TRPC3 ANKS1B ASAP2 NFKBIE ANKRD52 SHANK1 TRPC7 SLF1 ANK1 UACA ANKRD26 ANKRD50 SHANK3 KRIT1

1.90e-0625325215PS50088
DomainANK_REP_REGION

TANC2 TRPC3 ANKS1B ASAP2 NFKBIE ANKRD52 SHANK1 TRPC7 SLF1 ANK1 UACA ANKRD26 ANKRD50 SHANK3 KRIT1

1.99e-0625425215PS50297
DomainAnk

TANC2 TRPC3 ANKS1B ASAP2 NFKBIE ANKRD52 SHANK1 TRPC7 SLF1 ANK1 UACA ANKRD26 ANKRD50 KRIT1

2.79e-0622825214PF00023
DomainLRR_8

LRRC3C LRRC37A3 LRRK2 LRRC37A2 NRROS LRRC37A NTRK1 NTRK3 LRRC4B LRRTM2 LRRC8B LRRC28

3.70e-0617125212PF13855
DomainLRRC37AB_C

LRRC37A3 LRRC37A2 LRRC37A

9.61e-0642523IPR029423
DomainLRRC37AB_C

LRRC37A3 LRRC37A2 LRRC37A

9.61e-0642523PF14914
DomainLRRC37

LRRC37A3 LRRC37A2 LRRC37A

9.61e-0642523PF15779
DomainLRRC37_N

LRRC37A3 LRRC37A2 LRRC37A

9.61e-0642523IPR032754
DomainLRRC37A/B-like

LRRC37A3 LRRC37A2 LRRC37A

9.61e-0642523IPR015753
DomainLeu-rich_rpt_typical-subtyp

LRRC3C LRRC37A3 LRRK2 LRRC37A2 NRROS LRRC37A LRRC4B LRRTM2 LRRC8B LRRC28

1.50e-0417725210IPR003591
DomainLRR_TYP

LRRC3C LRRC37A3 LRRK2 LRRC37A2 NRROS LRRC37A LRRC4B LRRTM2 LRRC8B LRRC28

1.50e-0417725210SM00369
DomainSH3_2

ARHGEF6 SHANK1 DOCK2 MIA3 SHANK3 RIMBP2 RIMBP3B

1.63e-04862527PF07653
DomainSH3_2

ARHGEF6 SHANK1 DOCK2 MIA3 SHANK3 RIMBP2 RIMBP3B

1.63e-04862527IPR011511
Domainzf-TRAF_2

FBXO40 FBXO30

1.81e-0422522PF15965
DomainF-box_4

FBXO40 FBXO30

1.81e-0422522PF15966
DomainNPY4_rcpt

NPY4R2 NPY4R

1.81e-0422522IPR001933
DomainFbxo30/Fbxo40

FBXO40 FBXO30

1.81e-0422522IPR031890
DomainLRR_1

LRRC3C LRRC37A3 LRRK2 LRRC37A2 NRROS LRRC37A NTRK3 LRRC4B LRRTM2 LRRC8B LRRC28

1.99e-0421925211PF00560
DomainCH

IQGAP1 DST ARHGEF6 EHBP1 SYNE1 DIXDC1

2.41e-04652526SM00033
DomainLeu-rich_rpt

LRRC3C LRRC37A3 LRRK2 LRRC37A2 NRROS LRRC37A NTRK1 NTRK3 LRRC4B LRRTM2 LRRC8B LRRC28

3.30e-0427125212IPR001611
DomainCH

IQGAP1 DST ARHGEF6 EHBP1 SYNE1 DIXDC1

3.62e-04702526PF00307
DomainGAIN_dom_N

ADGRL2 CELSR1 CELSR3

3.70e-04112523IPR032471
DomainGAIN

ADGRL2 CELSR1 CELSR3

3.70e-04112523PF16489
Domain-

IQGAP1 DST ARHGEF6 EHBP1 SYNE1 DIXDC1

3.91e-047125261.10.418.10
DomainLRR

LRRC3C LRRC37A3 LRRK2 LRRC37A2 NRROS LRRC37A NTRK3 LRRC4B LRRTM2 LRRC8B

4.16e-0420125210PS51450
DomainCH

IQGAP1 DST ARHGEF6 EHBP1 SYNE1 DIXDC1

4.55e-04732526PS50021
DomainCH-domain

IQGAP1 DST ARHGEF6 EHBP1 SYNE1 DIXDC1

5.26e-04752526IPR001715
DomainNTRK_C2

NTRK1 NTRK3

5.39e-0432522IPR031635
DomainTPKR_C2

NTRK1 NTRK3

5.39e-0432522PF16920
DomainTyr_kinase_NGF_rcpt

NTRK1 NTRK3

5.39e-0432522IPR020777
DomainSH3

ASAP2 DST ARHGEF6 SHANK1 DOCK2 MIA3 ARHGAP9 SHANK3 RIMBP2 RIMBP3B

7.29e-0421625210PS50002
DomainSH3_domain

ASAP2 DST ARHGEF6 SHANK1 DOCK2 MIA3 ARHGAP9 SHANK3 RIMBP2 RIMBP3B

8.39e-0422025210IPR001452
DomainKASH

SYNE1 SYNE4

1.07e-0342522PS51049
DomainFERM_f0

SHANK1 SHANK3

1.07e-0342522PF16511
DomainNIDOGEN_G2

HMCN2 HMCN1

1.07e-0342522PS50993
DomainKASH

SYNE1 SYNE4

1.07e-0342522PF10541
DomainFERM_f0

SHANK1 SHANK3

1.07e-0342522IPR032425
DomainG2_nidogen/fibulin_G2F

HMCN2 HMCN1

1.07e-0342522IPR006605
DomainVDCC_a2/dsu

CACNA2D4 CACNA2D3

1.07e-0342522IPR013680
DomainKASH

SYNE1 SYNE4

1.07e-0342522IPR012315
DomainG2F

HMCN2 HMCN1

1.07e-0342522PF07474
DomainKASH

SYNE1 SYNE4

1.07e-0342522SM01249
DomainVGCC_alpha2

CACNA2D4 CACNA2D3

1.07e-0342522PF08473
DomainGFP

HMCN2 HMCN1

1.07e-0342522IPR009017
Domain-

LRRC3C LRRC37A3 LRRK2 LRRC37A2 NRROS LRRC37A NTRK1 NTRK3 LRRC4B LRRTM2 LRRC8B LRRC28

1.45e-03321252123.80.10.10
DomainL_dom-like

LRRC3C LRRC37A3 LRRK2 LRRC37A2 NRROS LRRC37A NTRK1 NTRK3 LRRC4B LRRTM2 LRRC8B LRRC28

1.74e-0332825212IPR032675
DomainB56

PPP2R5C PPP2R5D

1.77e-0352522PF01603
DomainPP2A_B56

PPP2R5C PPP2R5D

1.77e-0352522IPR002554
DomainVWA_N

CACNA2D4 CACNA2D3

1.77e-0352522IPR013608
DomainVWA_N

CACNA2D4 CACNA2D3

1.77e-0352522PF08399
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

TANC2 EPS15 ZNF219 ANKS1B IQGAP1 PARP1 DST AP2A2 UBR5 HERC2 UNC79 ARHGAP21 SHANK1 MIA3 UACA NPEPPS CAMK2B SYNE1 NBEA SHANK3 BCL11B PPP2R5D CDK5RAP2 RIMBP2 ADGRA1 DIXDC1 RPL12 PCNT

8.58e-109632572828671696
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

EPS15 HAUS6 HIVEP1 ZFYVE16 IRAK1 C15orf39 DST UBR5 ZNF644 ANKRD52 ARHGAP21 MRTFA EHBP1 TBC1D15 NELFCD ZKSCAN4 PCNT

1.81e-084182571734709266
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

FBXO40 HIVEP1 C15orf39 KIRREL2 HSPA12B FBXO30 DST ZNF653 SYNE1 PRDM4 SHANK3 PHF3 NCOA1

2.33e-082332571337704626
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

DCHS2 CLSTN3 PDE7A PEG10 MCF2L2 ANKS1B BRWD3 IQGAP1 PARP1 DST HPS4 HERC2 ARHGAP21 MTUS2 SHANK1 NDST1 CEP85 SYNE1 GNPTAB CHD9 NBEA PRDM4 INTS8 DALRD3 KRIT1 LIMK1 CELSR3 KDM4A CADPS2 PCNT

3.12e-0812852573035914814
Pubmed

Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.

ANKS1B IQGAP1 ASAP2 AP2A2 UBR5 SHANK1 CAMK2B SYNE1 NTRK3 NBEA SHANK3 PITPNM1 PHF3

2.07e-072812571328706196
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

CLSTN3 RIPOR2 ZFYVE16 UBR5 ZNF644 ARHGAP21 ZSWIM5 SYNE1 PHF3 LRRTM2 RIMBP2 UBE3C VPS13B PCNT PDZD2

4.46e-074072571512693553
Pubmed

Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.

MCF2L2 ASAP2 DST SEMA6A UACA CELSR3 CDK5RAP2 CADPS2 PDZD2

5.78e-07130257912421765
Pubmed

Expression analysis of the regenerating gene (Reg) family members Reg-IIIβ and Reg-IIIγ in the mouse during development.

FOXJ1 NTRK1 NTRK3 MUC5AC

5.91e-0710257421681751
Pubmed

A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum.

SEMA6A SHANK1 CAMK2B SHANK3 ZNF711 POLQ

8.57e-0744257632492419
Pubmed

Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

TANC2 HAUS6 UACA FBRSL1 NBEA MEAK7 CDK5RAP2 CADPS2

8.91e-07101257810997877
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

TANC2 EPS15 HAUS6 PAIP2 WDR55 IRAK1 C15orf39 PALMD UBR5 PIK3C2B NFKBIE ANKRD52 ARHGAP21 MRTFA EHBP1 TBC1D15 CEP85 HIRIP3 FBRSL1 ANKRD50 CBL SETD2 SHROOM1 PDE8B

9.62e-0710382572426673895
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

TANC2 SP100 ZNF219 IRAK1 EMILIN3 KAT2A BRWD3 PTPN14 HMCN2 UBR5 ACTL6B ADGRL2 ANKRD52 UACA FBRSL1 CHD9 TEP1 ZNF711 CCNT1 SETD2 ZNF526 BCL11B LRRC8B OSMR ZNF281

1.00e-0611162572531753913
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

TOX DST AP2A2 UBR5 DAGLA MRTFA NEMP1 SYNE1 GNPTAB PHF3 PCNT

1.05e-062252571112168954
Pubmed

Combinatorial CRISPR screen identifies fitness effects of gene paralogues.

KAT2A PARP1 AP2A2 USP42 DAGLA ARID4A ARFGEF1 CCNT1 CCNT2 LIMK1

1.39e-061862571033637726
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

TANC2 ZNF219 HIVEP1 LRRC37A3 NRROS HSPA12B FER1L6 FGD5 ANKRD52 FBRSL1 NBEA CBL ABCC6 ADAMTS6 NCOA1 CDK5RAP2 MPHOSPH10 ZNF281

1.53e-066382571831182584
Pubmed

Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.

LRRC37A3 LRRC37A2 LRRC37A

1.59e-064257322419166
Pubmed

Developmental expression profiles of Celsr (Flamingo) genes in the mouse.

ONECUT3 CELSR1 CELSR3

1.59e-064257311850187
Pubmed

The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.

DST AP2A2 DOCK2 EEFSEC TBC1D15 SYNE1 CCNT1 CCNT2 ZKSCAN4 ZNF281

2.34e-061972571020811636
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

IQGAP1 DST HPS4 ADGRL2 DAGLA NEMP1 RALGDS FBRSL1 SPG11 ANKRD50 PPP2R5C CELSR3 PDCD11 CDK5RAP2 KDM4A DIXDC1

2.45e-065292571614621295
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

TANC2 SPIRE2 EPPK1 IRAK1 C15orf39 KAT2A DST PIK3C2B POLL HERC2 ARHGAP21 NDST1 FBRSL1 TEP1 SYNE4 PHC2 NHSL1 CELSR1 CELSR3 SCARB1 ZNF335 PDCD11 UBE3C PCNT

2.83e-0611052572435748872
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

EPPK1 ABCA13 LRRK2 PARP1 ASAP2 DNHD1 CHD9 PHF3 CDK5RAP2 POLQ

3.80e-062082571033230847
Pubmed

Direction selectivity in the retina is established independent of visual experience and cholinergic retinal waves.

SCN11A TRPC3 MRTFA NTRK1 NTRK3

5.74e-0635257518498732
Pubmed

Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons.

SCN11A TRPC3 MRTFA NTRK1 NTRK3

7.61e-0637257518498735
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

RIPOR2 ZFYVE16 HERC2 ADAMTS3 CHD9 RIMBP2 PDZD2

1.28e-0510425779205841
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

TANC2 HAUS6 ASAP2 AP2A2 DOCK2 EHBP1 UACA GNPTAB ANKRD26 MEAK7 ATP8B2 SHANK3 SETD2 ZNF526

2.11e-054932571415368895
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

EPS15 ABCF3 ZFYVE16 IRAK1 IQGAP1 DST NFKBIE ADGRL2 ARHGAP21 EHBP1 UACA CBL NHSL1 PDLIM1 SCARB1

2.34e-055652571525468996
Pubmed

A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.

ZNF219 HIVEP1 TOX KAT2A ZNF235 IRX4 NFKBIE POU4F3 REST CBL PRDM4 IKZF4 LIMK1 BCL11B TRIM62 NCOA1 KDM4A

2.46e-057092571722988430
Pubmed

De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.

PPP2R3A PPP2R5C PPP2R5D

3.24e-059257330595372
Pubmed

Loss of the transcription factor Meis1 prevents sympathetic neurons target-field innervation and increases susceptibility to sudden cardiac death.

DST NTRK1 NTRK3 NBEA

3.83e-0526257426857994
Pubmed

Proximity interactions of the ubiquitin ligase Mind bomb 1 reveal a role in regulation of epithelial polarity complex proteins.

EPS15 HAUS6 PEG10 AP2A2 PIK3C2B ADGRL2 TBC1D15 ANKRD26

4.00e-05169257831462741
Pubmed

Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins.

CLSTN3 ADGRL2 NTRK1 NTRK3 LRRTM2

4.15e-0552257524613359
Pubmed

ADAMTS: a novel family of extracellular matrix proteases.

ADAMTS3 ADAMTS10 ADAMTS6

4.61e-0510257311167130
Pubmed

Evolutionary dynamism of the primate LRRC37 gene family.

LRRC37A3 LRRC37A2 LRRC37A

4.61e-0510257323064749
Pubmed

GemC1 controls multiciliogenesis in the airway epithelium.

FOXJ1 MUC5AC PCNT

4.61e-0510257326882546
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

EPS15 PDE7A PEG10 HSPA12B PARP1 PTPN14 UBR5 ZNF644 SEMA6A HERC2 ADGRL2 SUCO ANKRD52 MRPL50 TBC1D15 MIA3 UACA SYNE1 ANKRD26 SPG11 PPP2R5D PDCD11 CDK5RAP2 VPS13B RPL12 PCNT

4.74e-0514872572633957083
Pubmed

Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.

PAIP2 PTPN4 PTPN14 ANKRD52 ADIPOR2 EHBP1 RALGDS CEP85 DTNB NPEPPS REST CCNT1 KDM4A UBE3C

5.22e-055362571415840001
Pubmed

Exchangeable gene trap using the Cre/mutated lox system.

PAIP2 PTPN4 PTPN14 ANKRD52 ADIPOR2 EHBP1 RALGDS CEP85 DTNB NPEPPS REST CCNT1 KDM4A UBE3C

5.43e-055382571410512203
Pubmed

CCM2 expression parallels that of CCM1.

CCM2 KRIT1

5.44e-052257216373645
Pubmed

Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.

CCM2 KRIT1

5.44e-052257220308363
Pubmed

Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice.

SHANK1 SHANK3

5.44e-052257233402706
Pubmed

CCM1 and CCM2 variants in patients with cerebral cavernous malformation in an ethnically Chinese population in Taiwan.

CCM2 KRIT1

5.44e-052257231455779
Pubmed

Novel CCM2 missense variants abrogating the CCM1-CCM2 interaction cause cerebral cavernous malformations.

CCM2 KRIT1

5.44e-052257231937560
Pubmed

CCM2 mediates death signaling by the TrkA receptor tyrosine kinase.

CCM2 NTRK1

5.44e-052257219755102
Pubmed

Mutational analysis of CCM1, CCM2 and CCM3 in a Han Chinese cohort with multiple cerebral cavernous malformations in Taiwan.

CCM2 KRIT1

5.44e-052257229787619
Pubmed

Fine-needle aspiration cytomorphology of papillary thyroid carcinoma with NTRK gene rearrangement from a case series with predominantly indeterminate cytology.

NTRK1 NTRK3

5.44e-052257232931153
Pubmed

c-Cbl regulates αPix-mediated cell migration and invasion.

ARHGEF6 CBL

5.44e-052257225450678
Pubmed

Poly(ADP-ribosylation) of P-TEFb by PARP1 disrupts phase separation to inhibit global transcription after DNA damage.

PARP1 CCNT1

5.44e-052257235393539
Pubmed

Ligand-induced downregulation of TrkA is partly regulated through ubiquitination by Cbl.

NTRK1 CBL

5.44e-052257221570973
Pubmed

Update on Novel CCM Gene Mutations in Patients with Cerebral Cavernous Malformations.

CCM2 KRIT1

5.44e-052257228000143
Pubmed

Importance of the CEP215-pericentrin interaction for centrosome maturation during mitosis.

CDK5RAP2 PCNT

5.44e-052257224466316
Pubmed

S100 and Pan-Trk Staining to Report NTRK Fusion-Positive Uterine Sarcoma: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting.

NTRK1 NTRK3

5.44e-052257233290352
Pubmed

Cytomorphologic features of NTRK-rearranged thyroid carcinoma.

NTRK1 NTRK3

5.44e-052257233074583
Pubmed

Centriole-independent mitotic spindle assembly relies on the PCNT-CDK5RAP2 pericentriolar matrix.

CDK5RAP2 PCNT

5.44e-052257233170211
Pubmed

EPS15-NTRK1: a novel NTRK1 oncogenic fusion in patient with lung adenocarcinoma.

EPS15 NTRK1

5.44e-052257233037466
Pubmed

Downregulation of ARFGEF1 and CAMK2B by promoter hypermethylation in breast cancer cells.

CAMK2B ARFGEF1

5.44e-052257221871176
Pubmed

CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis.

CCM2 KRIT1

5.44e-052257216037064
Pubmed

Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutations.

CCM2 KRIT1

5.44e-052257217440989
Pubmed

Identification of NTRK fusions in pediatric mesenchymal tumors.

NTRK1 NTRK3

5.44e-052257228097808
Pubmed

Infantile NTRK-associated Mesenchymal Tumors.

NTRK1 NTRK3

5.44e-052257228683589
Pubmed

Combinatorial assembly of small molecules into bivalent antagonists of TrkC or TrkA receptors.

NTRK1 NTRK3

5.44e-052257224603864
Pubmed

Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining.

PARP1 POLQ

5.44e-052257233911081
Pubmed

Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues.

HMCN2 HMCN1

5.44e-052257232035013
Pubmed

Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations.

CCM2 KRIT1

5.44e-052257217290187
Pubmed

ADAMTS-10 and -6 differentially regulate cell-cell junctions and focal adhesions.

ADAMTS10 ADAMTS6

5.44e-052257227779234
Pubmed

Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.

CCM2 KRIT1

5.44e-052257225525273
Pubmed

Krit1/cerebral cavernous malformation 1 mRNA is preferentially expressed in neurons and epithelial cells in embryo and adult.

ACE KRIT1

5.44e-052257212204286
Pubmed

Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.

NTRK1 NTRK3

5.44e-052257232880785
Pubmed

NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.

NTRK1 NTRK3

5.44e-052257229553955
Pubmed

Testis developmental phenotypes in neurotropin receptor trkA and trkC null mutations: role in formation of seminiferous cords and germ cell survival.

NTRK1 NTRK3

5.44e-052257212021070
Pubmed

Evolutionary diversification of the BetaM interactome acquired through co-option of the ATP1B4 gene in placental mammals.

SYNE1 PHF3 RCN3

6.30e-0511257326939788
Pubmed

Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons.

NTRK1 NTRK3 POU4F3

6.30e-051125738955272
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

HIVEP1 IQGAP1 USP42 ZNF644 ARHGEF6 MRTFA HIRIP3 UACA ARID4A REST PHC2 PITPNM1 CCNT2 SETD2 PHF3 MAP4K1 ZNF335

7.26e-057742571715302935
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

HAUS6 IRAK1 ACE IQGAP1 PTPN14 UBR5 NFKBIE HERC2 ANKRD52 ARHGAP21 MIA3 ANKRD26 CP PPP2R3A PPP2R5D PDLIM1 UBE3C PCNT

7.41e-058532571828718761
Pubmed

A human MAP kinase interactome.

SP100 RIPOR2 HIVEP1 FBXO30 ASAP2 DST HPS4 HERC2 SHANK1 EHBP1 RALGDS SYNE1 CBL

7.61e-054862571320936779
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

SCN11A SP100 MYLK ANKS1B KAT2A FER1L6 IQGAP1 PARP1 DST AP2A2 ARHGAP21 ERICH6 NELFCD ZSWIM5 DTNB CAMK2B SYNE1 PCDHGA2 PCDHGA1 ANKRD26 SPG11 MPHOSPH10 POLQ CADPS2 PCNT

7.62e-0514422572535575683
Pubmed

Proper formation of whisker barrelettes requires periphery-derived Smad4-dependent TGF-beta signaling.

TRPC3 NTRK1 NTRK3 CACNA2D3

7.83e-0531257421300867
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

PTPN14 DST PIK3C2B SEMA6A ADGRL2 ARHGAP21 EHBP1 UACA ANKRD26 ANKRD50 CBL NHSL1

7.91e-054212571236976175
Pubmed

Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.

DST DNHD1 EEFSEC SYNE1 SETD2 CELSR3 MUC5AC PCNT

8.15e-05187257826460568
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

TANC2 SPIRE2 HIVEP1 FAM117A PTPN14 DST PIK3C2B ARHGAP21 EHBP1 NELFCD NTRK3 ANKRD26 CBL NHSL1 LIMK1 MTMR4 PHF3 MAP4K1

8.34e-058612571836931259
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

EPS15 HAUS6 ZFYVE16 IRAK1 IQGAP1 PARP1 DST ADGRL2 ARHGAP21 EHBP1 TBC1D15 ANKRD26 ANKRD50 PPP2R5D PDLIM1 RPL12

8.53e-057082571639231216
Pubmed

International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.

ADGRL2 CELSR1 CELSR3 ADGRA1

1.01e-0433257425713288
Pubmed

Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.

TOX HSPA12B MYCBPAP MIPEP MICA CP GRM7 HAPLN1

1.01e-04193257822589738
Pubmed

Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.

PPP2R3A PPP2R5C PPP2R5D

1.08e-0413257318971272
Pubmed

PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins.

PPP2R3A PPP2R5C PPP2R5D

1.08e-0413257321072166
Pubmed

Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

CLSTN3 TOX DST ADGRL2 MTUS2 SYNE1

1.08e-0410125769872452
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

ZFYVE16 WDR55 PARP1 PTPN4 PTPN14 HERC2 ADGRL2 ANKRD52 MIA3 CEP85 DTNB NBEA NHSL1 PPP2R3A MTMR4 PPP2R5C PPP2R5D CDK5RAP2 ZKSCAN4 PCNT

1.18e-0410492572027880917
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

ZNF219 HIVEP1 TOX KAT2A ZNF235 ZNF644 AEBP2 ZNF653 MRTFA ZSCAN5A REST PRDM4 LIMK1 PDLIM1 NCOA1 KDM4A ZKSCAN4

1.22e-048082571720412781
Pubmed

New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.

ABCA13 LRRK2 PARP1 DST HERC2 SHANK1 IQCH PHC2 BCL11B CELSR3 ADAMTS6 OSMR RPL12

1.30e-045132571325798074
Pubmed

Increasing the ratio of PP2A core enzyme to holoenzyme inhibits Tat-stimulated HIV-1 transcription and virus production.

PPP2R3A PPP2R5C PPP2R5D

1.37e-041425739400615
Pubmed

Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr.

PPP2R3A PPP2R5C PPP2R5D

1.37e-041425739013886
Pubmed

Association of Trk neurotrophin receptors with components of the cytoplasmic dynein motor.

AP2A2 NTRK1 NTRK3

1.37e-0414257311157096
Pubmed

Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription.

PPP2R3A PPP2R5C PPP2R5D

1.37e-0414257316048649
Pubmed

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.

HAUS6 PEG10 IRAK1 MIPEP MICA SLC26A2 DTNB NPEPPS ARFGEF1 SPG11 INTS8 MEAK7 ATP8B2 CCNT1 SETD2 PDLIM1 SCARB1 UBE3C EGFL7 OSMR

1.37e-0410612572033845483
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

HIVEP1 C15orf39 PTPN14 UBR5 PIK3C2B ZNF644 ANKRD52 CEP85 CAMK2B FBRSL1 ANKRD26 SETD2 ADO PCNT

1.38e-045882571438580884
Pubmed

Functional proteomics mapping of a human signaling pathway.

EPS15 HIVEP1 ZFYVE16 PEG10 DST AP2A2 UBR5 HERC2 NELFCD ARHGAP9 PRDM4 MTMR4 TRIM62 MPHOSPH10

1.46e-045912571415231748
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

HAUS6 ZFYVE16 IRAK1 PTPN14 ARHGAP21 EHBP1 MIA3 ANKRD26 VPS13B

1.62e-04263257934702444
Pubmed

Poly(A) binding protein (PABP) homeostasis is mediated by the stability of its inhibitor, Paip2.

PAIP2 UBR5

1.62e-043257216601676
Pubmed

Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere.

HMCN2 HMCN1

1.62e-043257212388743
Pubmed

Regulation of P-TEFb elongation complex activity by CDK9 acetylation.

CCNT1 CCNT2

1.62e-043257217452463
Pubmed

Molecular screening test in familial forms of cerebral cavernous malformation: the impact of the Multiplex Ligation-dependent Probe Amplification approach.

CCM2 KRIT1

1.62e-043257219199464
InteractionNCK1 interactions

PARP1 PTPN4 ASAP2 SEMA6A ADGRL2 ARHGAP21 ARHGEF6 ADIPOR2 NTRK1 NTRK3 CBL SHANK3 PHC2 NHSL1 MAP4K1 RPL12

7.61e-0824425116int:NCK1
InteractionRCOR1 interactions

EPS15 SP100 HAUS6 HIVEP1 PDGFRL ZFYVE16 IRAK1 C15orf39 DST UBR5 RECQL4 ANKRD52 ARHGAP21 MRTFA EHBP1 TBC1D15 ARID4A NELFCD ZSCAN5A REST

4.18e-0649425120int:RCOR1
InteractionNCK2 interactions

ANKS1B ASAP2 SEMA6A ONECUT3 ARHGAP21 ARHGEF6 ADIPOR2 TRIM15 MIA3 NTRK3 CBL NHSL1 ZNF526 MAP4K1

5.63e-0626225114int:NCK2
InteractionTNIK interactions

TANC2 ZNF219 HSPA12B DST AP2A2 HERC2 ARHGAP21 SHANK1 CAMK2B SYNE1 NTRK3 NBEA ANKRD50 SHANK3 BCL11B PPP2R5D RIMBP2

6.36e-0638125117int:TNIK
InteractionPHF21A interactions

EPS15 HAUS6 HIVEP1 ZFYVE16 IRAK1 C15orf39 DST UBR5 ANKRD52 ARHGAP21 MRTFA EHBP1 TBC1D15 NELFCD PCNT

2.83e-0534325115int:PHF21A
InteractionCRKL interactions

EPS15 SP100 LRRK2 PTPN4 RECQL4 DOCK2 NTRK1 ARHGAP9 CBL SHANK3 PHC2 MAP4K1

2.94e-0522725112int:CRKL
InteractionKCNA3 interactions

EPS15 HAUS6 EPPK1 ZFYVE16 ABCA13 LRRK2 IRAK1 IQGAP1 PARP1 ASAP2 DST ADGRL2 ARHGAP21 EHBP1 DNHD1 TBC1D15 ANKRD26 CHD9 ANKRD50 PPP2R5D NPY4R PDLIM1 PHF3 CDK5RAP2 POLQ RPL12

3.58e-0587125126int:KCNA3
GeneFamilyAnkyrin repeat domain containing

TANC2 ANKS1B ASAP2 NFKBIE ANKRD52 SHANK1 SLF1 ANK1 UACA ANKRD26 ANKRD50 SHANK3 KRIT1

8.95e-0724217913403
GeneFamilyAdhesion G protein-coupled receptors, subfamily C|CELSR cadherins

CELSR1 CELSR3

2.91e-0431792913
GeneFamilyAdhesion G protein-coupled receptors, subfamily C|CELSR cadherins

CELSR1 CELSR3

2.91e-04317921189
GeneFamilyWD repeat domain containing|Protein phosphatase 2 regulatory subunits

PPP2R3A PPP2R5C PPP2R5D

3.98e-04151793696
GeneFamilySpectrin repeat containing nuclear envelope family

SYNE1 SYNE4

5.77e-04417921252
GeneFamilyCyclins|P-TEFb complex

CCNT1 CCNT2

5.77e-04417921281
GeneFamilyPDZ domain containing

PTPN4 ARHGAP21 SHANK1 SHANK3 LIMK1 PDLIM1 PDZD2

8.04e-0415217971220
GeneFamilyADAM metallopeptidases with thrombospondin type 1 motif

ADAMTS3 ADAMTS10 ADAMTS6

8.23e-0419179350
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

MYLK PDGFRL KIRREL2 HMCN2 NTRK3 LRRC4B HMCN1

1.13e-031611797593
GeneFamilyEF-hand domain containing|Plakins

EPPK1 DST

2.62e-0381792939
GeneFamilyFibulins

HMCN2 HMCN1

2.62e-0381792556
GeneFamilyZinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases

ZSWIM4 ZSWIM5

3.35e-039179290
GeneFamilyZinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors

ZFYVE16 FGD5 MTMR4

3.50e-0331179381
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF219 HIVEP1 ZNF235 ZNF653 ZSCAN5A PRDM4 ZNF691 IKZF4 ZNF711 ZNF526 BCL11B ZNF425 ZNF335 ZKSCAN4 ZNF281

5.25e-037181791528
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HGABA

TANC2 RIPOR2 PDE7A STK32B LRRK2 FRS3 ANKS1B ACTL6B UNC79 MTUS2 RALGDS MIA3 ANK1 ADAMTS3 ARID4A CAMK2B NTRK3 GNPTAB ARFGEF1 APLP1 LRRC4B NBEA GRM7 SHANK3 IKZF4 PPP2R3A BCL11B CELSR3 LRRTM2 RIMBP2 PNCK

1.46e-07110625631M39071
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

EPS15 HAUS6 CLSTN3 RIPOR2 PDE7A TOX PAIP2 IQGAP1 PARP1 PTPN4 USP42 UBR5 ZNF644 TRIM38 ARHGEF6 DOCK2 RALGDS SLF1 ARID4A LONP2 SLC26A2 SYNE1 GNPTAB ARHGAP9 SPG11 REST CBL ATP8B2 CCNT2 SETD2 PPP2R5C BCL11B CD6 PHF3 MAP4K1 NCOA1 VPS13B

1.80e-07149225637M40023
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

EPS15 SP100 HIVEP1 ZFYVE16 PTPN4 ASAP2 DST UBR5 SUCO MRTFA EHBP1 ARID4A NPEPPS ARFGEF1 CHD9 SPG11 KRIT1 SETD2 PPP2R3A PPP2R5C PHF3 NCOA1 OSMR VPS13B PCNT

1.23e-0685625625M4500
CoexpressionLAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN

RIPOR2 SEMA3G HSPA12B ACE ASAP2 MICA FGD5 SEMA6A VEGFD HYAL1 SYNE1 SHANK3 SLC6A2 MAP4K1 EGFL7 ZKSCAN4 TNXB PDZD2

1.86e-0649125618MM455
CoexpressionGSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP

PDE7A BRWD3 HPS4 RHBDL1 ARHGAP9 GRM7 INTS8 PITPNM1 ADGB OSMR CADPS2

4.76e-0620025611M9391
CoexpressionCARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP

PDE7A C15orf39 SEMA3G HSPA12B FER1L6 B3GNT8 ASAP2 PTPN14 PIK3C2B ANKRD52 FOXJ1 UACA SLC26A2 PCDHGA1 ARMC9 MEAK7 ATP8B2 ZNF711 LIMK1 CELSR3 ADAMTS6 BTN2A3P CACNA2D3 RPL12

7.95e-0689125624M45033
CoexpressionGSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN

RGMB AP2A2 HPS4 KLHL6 DOCK2 NDST1 ADAMTS10 SETD2 NCOA1 VPS13B

1.24e-0518125610M8662
CoexpressionHE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL

SP100 CLSTN3 ZNF219 TOX PDGFRL PTPN14 SEMA6A RALGDS ADAMTS3 SLC26A2 APLP1 ARMC9 ANKRD50 GRM7 PHC2 NHSL1 ARSA SCARB1 UBE3C OSMR CADPS2 TNXB CACNA2D3 PDZD2

2.46e-0595525624M45680
CoexpressionGSE18281_CORTEX_VS_MEDULLA_THYMUS_DN

MYLK LAGE3 ASAP2 MIPEP ARHGEF6 EHBP1 ARHGAP9 APLP1 INTS8 DALRD3

2.47e-0519625610M7243
CoexpressionGSE17721_12H_VS_24H_POLYIC_BMDC_DN

HIVEP1 EPPK1 ABCF3 PARP1 PTPN14 MRTFA HS1BP3 TEP1 CDK5RAP2 MPHOSPH10

2.94e-0520025610M4102
CoexpressionGSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP

RIPOR2 ALS2CL CCM2 FAM117A POU4F3 IKZF4 CACNA2D4 BCL11B NCOA1 ZNF281

2.94e-0520025610M9205
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

EPS15 HIVEP1 ASAP2 DST UBR5 EHBP1 NPEPPS ARFGEF1 CHD9 KRIT1 SETD2 PPP2R3A PPP2R5C PHF3 NCOA1

6.05e-0546625615M13522
ToppCellLPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PALMD ACE ASAP2 DST PIK3C2B FGD5 SEMA6A ADGRL2 SLF1 UACA SHANK3 HMCN1 ADAMTS6 EGFL7

8.86e-12194258140b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PALMD NRROS HSPA12B ACE ASAP2 PIK3C2B FGD5 SEMA6A ADGRL2 SLF1 UACA SHANK3 EGFL7

1.10e-1019225813c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCellLPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PALMD NRROS HSPA12B ACE ASAP2 PIK3C2B FGD5 SEMA6A ADGRL2 SLF1 UACA SHANK3 EGFL7

1.10e-101922581304f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCellBronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SEMA3G PALMD HSPA12B FGD5 SEMA6A ADGRL2 ADIPOR2 UACA SHANK3 PDLIM1 ADAMTS6 SCARB1 EGFL7

1.52e-101972581381718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCellLPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HSPA12B ACE MYCBPAP ASAP2 FGD5 SEMA6A ADGRL2 SLF1 UACA HYAL1 SHANK3 EGFL7

1.45e-0919225812c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCellLPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PALMD HSPA12B ACE ASAP2 PIK3C2B FGD5 SEMA6A ADGRL2 SLF1 UACA SHANK3 EGFL7

1.54e-091932581202f633b016ab19bfa65bfd0cf32f000549a62148
ToppCellLPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PALMD HSPA12B ACE ASAP2 PIK3C2B FGD5 SEMA6A ADGRL2 SLF1 UACA SHANK3 EGFL7

1.54e-09193258125122b1ffba42de190061be34ecdc6176f84e56a3
ToppCellLPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PALMD HSPA12B ACE ASAP2 DST PIK3C2B FGD5 SEMA6A ADGRL2 UACA SHANK3 EGFL7

1.63e-091942581243f92b0533e26633dc94cce554045d641ef8fd76
ToppCellLPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PALMD HSPA12B ACE ASAP2 DST PIK3C2B FGD5 SEMA6A ADGRL2 UACA SHANK3 EGFL7

1.63e-09194258121d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA3G PALMD HSPA12B HMCN2 PIK3C2B FGD5 ADIPOR2 UACA SHANK3 SHROOM1 ADAMTS6 EGFL7

1.73e-09195258126bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SEMA3G PALMD HSPA12B FGD5 SEMA6A ADGRL2 ADIPOR2 UACA HYAL1 SHANK3 SCARB1 EGFL7

2.06e-09198258121d30a1f73b6d6d838f49751402a29c5ef54aa81f
ToppCellCOVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

SEMA3G PALMD PTPN14 HMCN2 PIK3C2B FGD5 ADIPOR2 SHANK3 PDLIM1 EGFL7 PDZD2

1.12e-08184258110f19494789f38ab1a420545e15e748ca7eb345c3
ToppCellControl-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HSPA12B ACE MYCBPAP SEMA6A ADGRL2 ARHGAP21 UACA HYAL1 SHANK3 SCARB1 EGFL7

1.33e-0818725811ea9d34bcd3bd1f36745846309ede349773de501a
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor

PALMD HSPA12B SEMA6A ADGRL2 ADIPOR2 UACA HYAL1 SHANK3 ADAMTS6 EGFL7 CADPS2

1.41e-081882581102a62888e9db29d20133eeca1686d302545a39c9
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HSPA12B ACE MYCBPAP FGD5 SEMA6A ADGRL2 UACA HYAL1 SHANK3 SCARB1 EGFL7

1.41e-081882581173f6ec915934154f435a376cb274b058ff7c5f35
ToppCellCOVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations)

SEMA3G PALMD FGD5 SEMA6A ADGRL2 ADIPOR2 SHANK3 PDLIM1 ADAMTS6 EGFL7 CADPS2

1.57e-0819025811812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCellCOVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

SEMA3G PALMD PIK3C2B FGD5 SEMA6A ADGRL2 SHANK3 PDLIM1 ADAMTS6 EGFL7 CADPS2

1.57e-08190258119fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCellP03-Endothelial-large_vessel_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TOX SEMA3G PALMD ACE ASAP2 DST KLHL6 SLC6A2 HMCN1 PDLIM1 EGFL7

1.66e-0819125811b680e0c35f1004be36f9f0680ae3c62952e2b607
ToppCellLPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PALMD ASAP2 PIK3C2B FGD5 SEMA6A ADGRL2 VWA2 SLF1 UACA SHANK3 EGFL7

1.84e-0819325811af5108260783e69a7d67896c5bf64f862525926d
ToppCellLPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PALMD ASAP2 FGD5 SEMA6A ADGRL2 SLF1 UACA SHANK3 HMCN1 ADAMTS6 EGFL7

1.84e-08193258116e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor

SEMA3G PALMD HSPA12B FGD5 SEMA6A ADGRL2 UACA HYAL1 SHANK3 ADAMTS6 EGFL7

1.84e-081932581139c6c96a2a100b1b290a779d36cc6bc17245720b
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA3G PALMD HSPA12B HMCN2 PIK3C2B FGD5 UACA SHANK3 SHROOM1 ADAMTS6 EGFL7

1.84e-0819325811cc355b2ed6510619cad969ae074126d7c8db784d
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SEMA3G PALMD HSPA12B ACE FGD5 VEGFD SHANK3 HMCN1 PDLIM1 EGFL7 CADPS2

2.05e-08195258114658fb197657d7692ee344ae76b11b0210c418ba
ToppCellBronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SEMA3G PALMD HSPA12B ACE ASAP2 PTPN14 PIK3C2B FGD5 ADIPOR2 SHANK3 EGFL7

2.16e-0819625811915e4a7422058be246b54760df31e8a607310625
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA3G PALMD HSPA12B HMCN2 UACA CP SHANK3 SHROOM1 ADAMTS6 EGFL7 TNXB

2.16e-0819625811a20a56d8997d6db2a10046c8801c619a379de83c
ToppCellEndothelial-capillary_endothelial_cell_(Cap1)|World / Lineage, Cell type, age group and donor

SEMA3G PALMD HSPA12B ACE FGD5 SEMA6A ADGRL2 UACA SLC26A2 SHANK3 EGFL7

2.16e-08196258110ce3ed27d2b9276390952652c17a8d6de13add36
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SEMA3G PALMD HSPA12B ACE FGD5 ADGRL2 SHANK3 HAPLN1 HMCN1 PDLIM1 EGFL7

2.40e-0819825811218f33e068eb126458ec33176de3cfa6fc06ddf0
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SEMA3G PALMD HSPA12B ACE FGD5 ADGRL2 SHANK3 HAPLN1 HMCN1 PDLIM1 EGFL7

2.40e-08198258117cddd474416651088a4e08edfc0ac420ff10a5fe
ToppCelltumor_Lung-Endothelial_cells-Tumor_ECs|tumor_Lung / Location, Cell class and cell subclass

PALMD HSPA12B ACE FGD5 SEMA6A ADGRL2 NDST1 UACA SHANK3 PDLIM1 EGFL7

2.40e-08198258115228c4bf2513186140c2c4eaa67a268c732bdc84
ToppCellBronchial-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PALMD HSPA12B FGD5 SEMA6A ADGRL2 UACA SHANK3 PDLIM1 ADAMTS6 SCARB1 EGFL7

2.40e-0819825811a1ccbf0e653b2dd665c2254920eb9b37243cc0bd
ToppCellBronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PALMD HSPA12B FGD5 SEMA6A ADGRL2 UACA SHANK3 PDLIM1 ADAMTS6 SCARB1 EGFL7

2.53e-081992581136a230b80096455df26c2e2c8c05fd6b231508c5
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PALMD HSPA12B ACE FGD5 SEMA6A ADGRL2 UACA HYAL1 SHANK3 SCARB1 EGFL7

2.53e-0819925811d58edc5f74970bb26d844746184e4bae7c494d6b
ToppCellLPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PALMD NRROS HSPA12B ACE ASAP2 DST ADGRL2 SLF1 UACA HYAL1 EGFL7

2.66e-08200258111d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCellLPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PALMD NRROS HSPA12B ACE ASAP2 DST ADGRL2 SLF1 UACA HYAL1 EGFL7

2.66e-082002581160d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

PALMD ACE ASAP2 DST UBR5 ADGRL2 SLF1 UACA HMCN1 EGFL7 PCNT

2.66e-0820025811dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA3G PALMD PIK3C2B UACA CP APLP1 SHROOM1 SLC15A1 ADAMTS6 TRIM62

4.12e-08163258101feb4ef7b8abcfca9a72c8d13c40548de79e7db2
ToppCell356C-Endothelial_cells-Endothelial-B_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells)

SEMA3G PALMD ACE PIK3C2B SEMA6A UACA RAB44 SHANK3 LRRTM2 EGFL7

5.80e-0816925810605cc2638271803cf1d972ab3fa8f13f89666376
ToppCell356C-Endothelial_cells-Endothelial-B_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells)

SEMA3G PALMD ACE PIK3C2B SEMA6A UACA RAB44 SHANK3 LRRTM2 EGFL7

5.80e-0816925810337be3bf485b54afad86e256cb0c4c1d0c2a9a2a
ToppCell3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SEMA3G PALMD ACE PTPN14 PIK3C2B FGD5 UACA APLP1 ADAMTS6 EGFL7

7.63e-081742581018ab52d8bbca0507fee220e0c4fc765fc47dda34
ToppCellLPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HSPA12B ACE MYCBPAP FGD5 SEMA6A ADGRL2 UACA HYAL1 SCARB1 EGFL7

1.05e-0718025810544fb373a3346186ec60afe2cfcf141bb04a1eed
ToppCellCOVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

HSPA12B ACE FGD5 SEMA6A ADGRL2 SYNE1 SHANK3 PDLIM1 EGFL7 CADPS2

1.11e-0718125810c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

DCHS2 HSPA12B ACE FGD5 SEMA6A ADGRL2 UACA SHANK3 SCARB1 EGFL7

1.16e-0718225810a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50
ToppCellControl-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SP100 HSPA12B ACE MYCBPAP PTPN4 SEMA6A ADGRL2 UACA SHANK3 EGFL7

1.22e-0718325810e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor

SEMA3G PALMD HSPA12B ACE FGD5 SEMA6A ADGRL2 SHANK3 ADAMTS6 EGFL7

1.36e-071852581007f9f38f0739d7c830641723a38385550ac1ac92
ToppCellCOVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type

PALMD PIK3C2B FGD5 SEMA6A ADGRL2 SHANK3 PDLIM1 ADAMTS6 EGFL7 CADPS2

1.57e-0718825810d582b76fc2faac526c9bf97503041129e1a6a211
ToppCellAdult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor

HSPA12B ACE FGD5 SEMA6A ADGRL2 UACA SYNE1 SHANK3 PDLIM1 EGFL7

1.57e-0718825810e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA3G PALMD HSPA12B ANK1 UACA SHANK3 SHROOM1 ADAMTS6 EGFL7 TNXB

1.57e-0718825810a37edd8f9e4a4e336b5acbb0407d3d275975cee8
ToppCellPND07-28-samps-Endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass

HSPA12B ACE ALS2CL PIK3C2B FGD5 SEMA6A ADGRL2 SHANK3 ZNF711 EGFL7

1.65e-0718925810eb2f8c8a90e5e9f6697a2d13274c94f40e1973e4
ToppCellPND07-28-samps-Endothelial-Postnatal_endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass

HSPA12B ACE ALS2CL PIK3C2B FGD5 SEMA6A ADGRL2 SHANK3 ZNF711 EGFL7

1.65e-0718925810d4a25d59d88325d3b20f4287e9b1160c82961a96
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

HSPA12B ACE FGD5 SEMA6A ADGRL2 UACA SYNE1 SHANK3 EGFL7 CADPS2

1.65e-0718925810b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCellEndothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor

SEMA3G PALMD HSPA12B PTPN14 PIK3C2B FGD5 SHANK3 HMCN1 ADAMTS6 EGFL7

1.65e-0718925810fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA3G PALMD HMCN2 PIK3C2B FGD5 UACA SHANK3 SHROOM1 ADAMTS6 EGFL7

1.65e-07189258106463890d8dbee4bc198f91628a5f784970de786a
ToppCellLPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HSPA12B ACE MYCBPAP PIK3C2B FGD5 SEMA6A ADGRL2 SLF1 UACA EGFL7

1.74e-0719025810474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

DCHS2 HSPA12B FGD5 SEMA6A ADGRL2 UACA HYAL1 SYNE1 SHANK3 EGFL7

1.74e-07190258100a351609a72fd638c84b2435782e312ee6a33aac
ToppCell10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SEMA3G PALMD HSPA12B ACE ADGRL2 ANK1 ADAMTS3 HYAL1 EGFL7 CADPS2

1.74e-071902581006bfb62b94b0faf467ef93d5bc5d08924c770098
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

HSPA12B FGD5 SEMA6A ADGRL2 UACA HYAL1 SYNE1 SHANK3 EGFL7 CADPS2

1.74e-07190258100e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCelldroplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PALMD HSPA12B ACE ASAP2 FGD5 SEMA6A ADGRL2 SYNE1 HMCN1 EGFL7

1.74e-0719025810e64b191f928935484e2c993d7f8af0572a617a3a
ToppCellPND01-Endothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SEMA3G PALMD HSPA12B ACE FGD5 SEMA6A SHANK3 HAPLN1 SCARB1 EGFL7

1.82e-071912581096b9b0aaf0cb2d6f929ff563dbaedc83ffb4795e
ToppCellE16.5-samps-Endothelial-Immature_fetal_endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass

PALMD NRROS ACE PIK3C2B FGD5 SEMA6A ADGRL2 SHANK3 HAPLN1 EGFL7

1.82e-071912581044c596984c6196f6014e0e405dbe5560841e54ff
ToppCellControl-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class

SEMA3G PALMD HSPA12B SEMA6A ADGRL2 SYNE1 SHANK3 EGFL7 OSMR CADPS2

1.82e-0719125810c672c8e28d06d555335976b3f8bd2ea6d3b34aae
ToppCellE16.5-samps-Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass

PALMD NRROS ACE PIK3C2B FGD5 SEMA6A ADGRL2 SHANK3 HAPLN1 EGFL7

1.82e-0719125810e7521d4d24f016d4e531cd492a7a69604f0c9e6f
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor

HSPA12B ACE FGD5 SEMA6A ADGRL2 UACA SYNE1 SHANK3 EGFL7 CADPS2

1.82e-0719125810f229abf69a1217194f74b0502486907e07dba989
ToppCellControl-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class

SEMA3G PALMD HSPA12B SEMA6A ADGRL2 SYNE1 SHANK3 EGFL7 OSMR CADPS2

1.82e-0719125810322237793a1278bafb14e63cab688b353e352dcc
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA3G PALMD HSPA12B HMCN2 PIK3C2B FGD5 CP SHANK3 ADAMTS6 EGFL7

1.91e-07192258103259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA3G PALMD HSPA12B PIK3C2B FGD5 ADIPOR2 SHANK3 SHROOM1 ADAMTS6 EGFL7

1.91e-0719225810bacbaef1f230051335f4433e55db07a161b96b4c
ToppCellPND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SEMA3G PALMD HSPA12B ACE ASAP2 DST PIK3C2B FGD5 UACA EGFL7

1.91e-0719225810285a9d332a1e07b94f222d4b518dd56928b9e075
ToppCellControl-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PALMD ACE ASAP2 FGD5 SEMA6A UACA SHANK3 HMCN1 EGFL7 CADPS2

2.01e-0719325810e1d546165dcc2392f540162206852c4717d7306f
ToppCellLPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HSPA12B ACE MYCBPAP FGD5 SEMA6A ADGRL2 UACA HYAL1 ANKRD50 EGFL7

2.01e-0719325810a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCellPND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SEMA3G PALMD HSPA12B ACE ASAP2 DST FGD5 SLC6A2 HMCN1 EGFL7

2.01e-071932581058c590dd6f21bc7ae58ae1729dd574c0f1069592
ToppCellControl-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HSPA12B ACE ASAP2 FGD5 SEMA6A ADGRL2 UACA SHANK3 EGFL7 CADPS2

2.01e-0719325810aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA3G PALMD HSPA12B PTPN14 PIK3C2B FGD5 UACA SHANK3 ADAMTS6 EGFL7

2.01e-07193258102e72309607902dabe3218888b22a77fe941f3570
ToppCellControl-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HSPA12B ACE ASAP2 FGD5 SEMA6A ADGRL2 UACA SHANK3 EGFL7 CADPS2

2.01e-0719325810c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCellCOVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

PALMD HSPA12B ASAP2 FGD5 ADGRL2 SYNE1 SHANK3 PDLIM1 EGFL7 CADPS2

2.01e-0719325810979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

SEMA3G PALMD PIK3C2B SEMA6A ADGRL2 UACA HYAL1 SHANK3 ADAMTS6 EGFL7

2.11e-071942581068004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCellLPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ACE ASAP2 PIK3C2B FGD5 SEMA6A ADGRL2 SLF1 UACA SHANK3 EGFL7

2.11e-071942581058f069efdefa0366033764446b9d6ffd4a17807e
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

SEMA3G PALMD SEMA6A ADGRL2 ADIPOR2 HYAL1 SYNE1 SHANK3 ADAMTS6 EGFL7

2.11e-071942581040842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCellLPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ACE ASAP2 PIK3C2B FGD5 SEMA6A ADGRL2 SLF1 UACA SHANK3 EGFL7

2.11e-0719425810bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCellcellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SCN11A SEMA3G PALMD HSPA12B ACE PIK3C2B FGD5 ANK1 ADAMTS6 EGFL7

2.21e-071952581075db19c0371320ea5fce1d6de8c1b40b1e6a2e58
ToppCellCOVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type

ACE FGD5 SEMA6A ADGRL2 UACA SYNE1 SHANK3 SCARB1 EGFL7 CADPS2

2.32e-071962581049cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCellFetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PALMD HSPA12B ACE PIK3C2B FGD5 SEMA6A ADGRL2 SHANK3 SCARB1 EGFL7

2.32e-07196258103981f6c7487598f4f7ce4650ac0ac5bd41481d66
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PALMD HSPA12B FGD5 HYAL1 SHANK3 HMCN1 PDLIM1 ADAMTS6 EGFL7 TNXB

2.32e-0719625810e224338490691d92c1f70b57112fabdcc92b06a9
ToppCellCOVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type

ACE FGD5 SEMA6A ADGRL2 UACA SYNE1 SHANK3 SCARB1 EGFL7 CADPS2

2.32e-07196258104ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCellCOVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type

PALMD FGD5 SEMA6A ADGRL2 ADIPOR2 UACA SHANK3 ADAMTS6 EGFL7 CADPS2

2.43e-07197258107e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PALMD HSPA12B FGD5 HYAL1 SHANK3 HMCN1 PDLIM1 ADAMTS6 EGFL7 TNXB

2.43e-0719725810c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PALMD HSPA12B FGD5 HYAL1 SHANK3 HMCN1 PDLIM1 ADAMTS6 EGFL7 TNXB

2.43e-07197258102844dbcd0a673ed81c99920aa45858651a00736d
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SEMA3G PALMD ANGPTL8 PIK3C2B FGD5 SHANK3 PDLIM1 ADAMTS6 EGFL7

2.53e-0715125893b4c57bad61e17a573e6f8dc6b917fba5fd56c43
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SP100 SEMA3G PALMD HSPA12B PIK3C2B FGD5 SHANK3 ADAMTS6 EGFL7 TNXB

2.55e-0719825810953630dbe3154b1b102b87de0feca2cbf124eabe
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SP100 SEMA3G PALMD HSPA12B PIK3C2B FGD5 SHANK3 ADAMTS6 EGFL7 TNXB

2.55e-07198258108e45551224fbb30c0658ad47dd98335ecf165437
ToppCellParenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PALMD HSPA12B ACE FGD5 SEMA6A ADGRL2 UACA SHANK3 SCARB1 EGFL7

2.67e-0719925810a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e
ToppCell10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SEMA3G PALMD HSPA12B ACE CYP39A1 ALS2CL VWA2 HYAL1 HMCN1 EGFL7

2.67e-0719925810236b1417ed0875e98c6ec1ec714003bfce438d65
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HSPA12B ACE FGD5 SEMA6A ADGRL2 UACA HYAL1 SHANK3 SCARB1 EGFL7

2.67e-0719925810dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53
ToppCellBronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TRPC3 SEMA3G PALMD PTPN14 PIK3C2B ANK1 HYAL1 APLP1 ADAMTS6 EGFL7

2.67e-07199258106a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCellHematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

PALMD IQGAP1 ADGRL2 ADIPOR2 UACA SYNE1 SHANK3 SHROOM1 EGFL7 PDZD2

2.79e-0720025810032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCellParenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

SEMA3G PALMD HSPA12B ACE PTPN14 PIK3C2B FGD5 SHANK3 ADAMTS6 EGFL7

2.79e-072002581034b279804475ea58fbb052b96f44128c082627a9
ToppCellLung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

SEMA3G PALMD HSPA12B ACE PTPN14 PIK3C2B FGD5 SHANK3 ADAMTS6 EGFL7

2.79e-07200258108552cc7a439449b30b59760c3e8667217b9852b5
ToppCell10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SEMA3G PALMD HSPA12B ACE ADGRL2 VWA2 UACA HMCN1 PDLIM1 EGFL7

2.79e-072002581086ec951234015ced7126b016199e5869a0f22478
ToppCellHematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

PALMD IQGAP1 ADGRL2 ADIPOR2 UACA SYNE1 SHANK3 SHROOM1 EGFL7 PDZD2

2.79e-072002581068fce28690246895fd33354b30960ebcc31aa4cc
ToppCellLPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYLK HSPA12B ACE MYCBPAP DST ADGRL2 UACA HYAL1 ANKRD50 EGFL7

2.79e-072002581079e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

NRROS HSPA12B ACE MYCBPAP FGD5 ADGRL2 UACA HYAL1 SCARB1 EGFL7

2.79e-0720025810b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PALMD NRROS HSPA12B ACE ASAP2 ADGRL2 SLF1 UACA HYAL1 EGFL7

2.79e-072002581058a7ece7dfdf6c46f2a50cbcb580574dec14c748
DrugTriamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A

EPPK1 MYLK PDGFRL EHBP1 ADAMTS3 APLP1 REST DALRD3 CCNT1 PHF3 SCARB1 RCN3

2.23e-06196254121819_DN
DiseaseIntellectual Disability

TANC2 BRWD3 PARP1 ACTL6B NDST1 RALGDS CAMK2B SYNE1 NBEA ARMC9 SHANK3 SETD2 ZNF526 BCL11B PPP2R5D ZNF335

1.76e-0644725216C3714756
Diseasehereditary sensory neuropathy (implicated_via_orthology)

SCN11A DST NTRK1

6.08e-0652523DOID:0050548 (implicated_via_orthology)
DiseaseSchizophrenia

ABCA13 ACE ALS2CL HPS4 NPAS1 SHANK1 ADAMTS3 CAMK2B NTRK1 NTRK3 CP REST GRM7 SHANK3 PITPNM1 SLC6A2 DIXDC1 ZKSCAN4 CADPS2 TNXB PCNT

2.62e-0588325221C0036341
DiseaseColorectal Carcinoma

CLSTN3 GALNS PDGFRL ABCA13 PAIP2 MCF2L2 FBXO30 PARP1 C12orf76 VWA2 SHANK1 RALGDS ZSCAN5A SYNE1 ARFGEF1 ABCC6 HAPLN1 BCL11B

3.84e-0570225218C0009402
DiseaseCavernous Angioma, Central Nervous System

CCM2 KRIT1

7.27e-0522522C1956260
DiseaseCerebral Cavernous Hemangioma

CCM2 KRIT1

7.27e-0522522C1140710
DiseaseCavernous Hemangioma, Intracerebral

CCM2 KRIT1

7.27e-0522522C0752164
DiseaseCavernous Hemangioma, Extracerebral

CCM2 KRIT1

7.27e-0522522C0752161
DiseaseHemangioma, Cavernous, Central Nervous System

CCM2 KRIT1

7.27e-0522522C0752160
Diseaseinternet addiction disorder

IRAK1 ANK1 NTRK3 PNCK

1.75e-04332524EFO_0803368
DiseaseCavernous Hemangioma of Brain

CCM2 KRIT1

2.17e-0432522C2919945
Diseaseautism spectrum disorder (implicated_via_orthology)

SHANK1 NDST1 CHD9 NBEA SHANK3 SLC6A2 CADPS2

3.45e-041522527DOID:0060041 (implicated_via_orthology)
Diseaselymphocyte count

RIPOR2 HIVEP1 EPPK1 IRAK1 IQGAP1 PTPN4 ZNF644 MICA VWA2 MRTFA DOCK2 ANK1 PCDHGA2 PCDHGA1 NTRK1 REST CBL MEAK7 SETD2 BCL11B ARSA CD6 ADO GYPA SCARB1 BTN2A3P

3.58e-04146425226EFO_0004587
Diseasepeak expiratory flow

STK32B ASAP2 DST PIK3C2B MRTFA ARID4A HAPLN1 ADAMTS10 SLC9A3 SLC15A1 GYPA NCOA1 CACNA2D3

3.89e-0449825213EFO_0009718
DiseaseCerebral cavernous malformation

CCM2 KRIT1

4.31e-0442522cv:C2919945
DiseaseHereditary cavernous hemangioma of brain

CCM2 KRIT1

4.31e-0442522cv:C2931263
Diseasecoronary artery disease

STK32B KAT2A ALS2CL PARP1 CCM2 ASAP2 FGD5 ADGRL2 ARHGAP21 MRTFA EHBP1 MIA3 ADAMTS3 ARID4A REST ANKRD50 PPP2R3A SLC15A1 SCARB1 ZNF335 MPHOSPH10 TNXB

6.35e-04119425222EFO_0001645
Diseasenephritis (is_implicated_in)

ACE PARP1

7.14e-0452522DOID:10952 (is_implicated_in)
DiseaseKyphosis deformity of spine

PARP1 SLC26A2

7.14e-0452522C0022821
DiseaseSarcosine measurement

PCDHGA2 PCDHGA1 PPP2R5D

9.61e-04232523EFO_0021668
Diseasevital capacity

DST PIK3C2B ADGRL2 DAGLA ARHGEF6 EHBP1 NDST1 IQCH ADAMTS3 CAMK2B SYNE1 GRM7 ADAMTS10 HMCN1 ADAMTS6 GYPA SCARB1 NCOA1 EGFL7 TNXB CACNA2D3 PDZD2

9.95e-04123625222EFO_0004312
Diseaseplatelet-to-lymphocyte ratio

RIPOR2 IQGAP1 PTPN4 MICA ZSWIM4 TRIM38 ANK1 CBL MEAK7 BTN2A3P

1.21e-0336325210EFO_0008446
Diseasetriacylglycerol 52:6 measurement

GRM7 CACNA2D4 EGFL7

1.23e-03252523EFO_0010418
Diseasemean platelet volume

HAUS6 TRPC3 LRRK2 MICA ACTL6B MRTFA ARID4A NELFCD NPEPPS PCDHGA2 PCDHGA1 FBRSL1 CHD9 REST MEAK7 SHANK3 SETD2 ARSA PDLIM1

1.31e-03102025219EFO_0004584
Diseaseforced expiratory volume

RGMB DST PIK3C2B C12orf76 ADGRL2 EEFSEC ANK1 SYNE1 REST IKZF4 PDE8B GYPA SCARB1 EGFL7 TNXB CACNA2D3

1.33e-0378925216EFO_0004314
DiseasePhencyclidine-Related Disorders

CAMK2B SCARB1

1.48e-0372522C0236742
Diseasebifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 measurement

NDST1 GNPTAB

1.48e-0372522EFO_0802332
DiseaseCongenital Pain Insensitivity

SCN11A NTRK1

1.48e-0372522C0002768
DiseasePhencyclidine Abuse

CAMK2B SCARB1

1.48e-0372522C0031391
DiseaseHereditary Sensory Autonomic Neuropathy, Type 5

SCN11A NTRK1

1.48e-0372522C0020075
Diseasesphingomyelin 24:0 measurement

PDGFRL TECTB

1.48e-0372522EFO_0010397
DiseaseAutistic Disorder

FBXO40 ACE SHANK1 CP NBEA SHANK3 DIXDC1 CADPS2

1.91e-032612528C0004352
Diseasecytotoxicity measurement, response to clozapine

TOX SHANK1 HMCN1

1.91e-03292523EFO_0006952, GO_0097338
DiseaseMental Retardation, X-Linked

BRWD3 ARHGEF6 ZNF711

1.91e-03292523C1136249
DiseaseAutosomal dominant nonsyndromic hearing loss

RIPOR2 POU4F3 REST

1.91e-03292523cv:C5779548
Diseasearylsulfatase A measurement

GNPTAB ARSA

1.97e-0382522EFO_0020163
Diseasecathepsin S measurement

MIA3 GNPTAB

1.97e-0382522EFO_0008073
Diseasemonocyte count

SP100 HIVEP1 NFKBIE VWA2 MRTFA EEFSEC ANK1 ZSCAN5A ARHGAP9 ARMC9 REST CBL MEAK7 SETD2 LIMK1 ADO GYPA SCARB1 BTN2A3P NCOA1 LRRC8B EGFL7

2.26e-03132025222EFO_0005091
Diseasefacial morphology measurement

DCHS2 CPED1 ONECUT3 MRTFA EEFSEC ANKRD50 GRM7 NHSL1 CADPS2 VPS13B CACNA2D3

2.37e-0346625211EFO_0007841
Diseasefibrinogen measurement

DCHS2 CHD9 SHANK3 PPP2R3A ARSA

2.48e-031092525EFO_0004623
Diseaseangiotensin-converting enzyme measurement

TANC2 ACE

2.51e-0392522EFO_0006515
Diseaseinterleukin-36 alpha measurement

EGFL7 TNXB

2.51e-0392522EFO_0021851
Diseaseheart conduction disease (implicated_via_orthology)

CAMK2B SLC6A2 CACNA2D3

2.54e-03322523DOID:10273 (implicated_via_orthology)
Diseasechronic obstructive pulmonary disease

DCHS2 LRRC37A2 ASAP2 AEBP2 EHBP1 EEFSEC TRIM15 BCL11B HMCN1 GYPA TRIM62 ZKSCAN4 CACNA2D3 PDZD2

2.54e-0368825214EFO_0000341
DiseaseCannabis Abuse

CAMK2B SCARB1

3.12e-03102522C0006868
DiseaseCannabis-Related Disorder

CAMK2B SCARB1

3.12e-03102522C0236735
DiseaseHashish Abuse

CAMK2B SCARB1

3.12e-03102522C0018614
Diseasetestosterone measurement

DCHS2 HAUS6 ZNF219 ANKS1B IQGAP1 ADGRL2 TRIM38 ARHGAP21 ARHGEF6 MIA3 TRPC7 ADAMTS3 NPEPPS ARHGAP9 BCL11B ADO HMCN1 PDE8B SCARB1 NCOA1 RIMBP2

3.25e-03127525221EFO_0004908
Diseasemyocardial infarction

CCM2 FGD5 EHBP1 MIA3 REST PPP2R3A SLC15A1 SCARB1 PDZD2

3.32e-033502529EFO_0000612
Diseasecerebral cavernous malformation (implicated_via_orthology)

CCM2 KRIT1

3.80e-03112522DOID:0060669 (implicated_via_orthology)
Diseasegastric adenocarcinoma (is_implicated_in)

ABCA13 UBR5

3.80e-03112522DOID:3717 (is_implicated_in)
Diseasemean reticulocyte volume

SPIRE2 RIPOR2 TRPC3 IRAK1 C15orf39 KAT2A CPED1 FAM117A ARHGAP21 ANK1 NPEPPS FBRSL1 REST GYPA EGFL7

3.85e-0379925215EFO_0010701
Diseasered blood cell density measurement

ZNF219 HIVEP1 DST UBR5 FGD5 ANK1 FBRSL1 ATP8B2 ABCC6 PHC2 BCL11B ADO PDE8B GYPA KDM4A VPS13B

3.91e-0388025216EFO_0007978
DiseaseManic

TRPC3 NTRK1 SHANK3 DIXDC1

4.52e-03782524C0338831
Diseasenicotine dependence (implicated_via_orthology)

TRPC3 TRPC7

4.53e-03122522DOID:0050742 (implicated_via_orthology)
DiseaseAbruptio Placentae

PDGFRL DOCK2

4.53e-03122522EFO_1001754
Diseasewaist-hip ratio, body mass index

ANKS1B DOCK2

4.53e-03122522EFO_0004340, EFO_0004343
DiseaseFEV/FEC ratio

DCHS2 ANKS1B PTPN4 ASAP2 DST AEBP2 MRTFA KLHL6 EEFSEC PCDHGA1 REST MEAK7 IKZF4 HAPLN1 LIMK1 ADO HMCN1 GYPA TNXB CACNA2D3

4.58e-03122825220EFO_0004713
DiseaseSarcomatoid Renal Cell Carcinoma

LRRK2 SHANK1 DNHD1 SETD2 SCARB1

4.93e-031282525C1266043
DiseaseChromophobe Renal Cell Carcinoma

LRRK2 SHANK1 DNHD1 SETD2 SCARB1

4.93e-031282525C1266042
DiseaseCollecting Duct Carcinoma of the Kidney

LRRK2 SHANK1 DNHD1 SETD2 SCARB1

4.93e-031282525C1266044
DiseasePapillary Renal Cell Carcinoma

LRRK2 SHANK1 DNHD1 SETD2 SCARB1

4.93e-031282525C1306837
DiseaseRenal Cell Carcinoma

LRRK2 SHANK1 DNHD1 SETD2 SCARB1

4.93e-031282525C0007134
Diseasebilirubin measurement

DCHS2 MIPEP ADGRL2 ANK1 ANKRD50 MEAK7 PPP2R3A GYPA SCARB1 LRRC8B

4.96e-0344225210EFO_0004570
DiseaseMajor Depressive Disorder

ACE NTRK3 REST GRM7 SLC6A2 ARSA PCNT

5.06e-032432527C1269683
DiseaseTinnitus

UMAD1 EHBP1 FBRSL1 BCL11B CACNA2D3

5.26e-031302525HP_0000360
DiseaseMental Retardation, X-Linked Nonsyndromic

ARHGEF6 ZNF711

5.33e-03132522C3501611
Diseasesevere acute respiratory syndrome, COVID-19

PTPN4 AEBP2 TRPC7 DTNB GRM7 SLC15A1 RIMBP2 CADPS2 CACNA2D3 PDZD2

5.36e-0344725210EFO_0000694, MONDO_0100096
Diseaseasthma

LRRC3C HIVEP1 TRPC3 NRROS AP2A2 UNC79 EEFSEC NEMP1 CEP85 IKZF4 GYPA CDK5RAP2 MUC5AC PCNT

5.48e-0375125214MONDO_0004979
Diseasebasal cell carcinoma

HAUS6 SPIRE2 HERC2 FBRSL1 IKZF4 EGFL7

5.84e-031892526EFO_0004193
Diseaseamino acid measurement

TANC2 ZFYVE16 ADGRL2 MTUS2 MRTFA SYNE1 ARHGAP9 GRM7 PHC2 HAPLN1 SLC6A2 CCNT2 CD6

5.85e-0367825213EFO_0005134
Diseaseanemia (is_implicated_in)

ACE ANK1

6.18e-03142522DOID:2355 (is_implicated_in)
Diseasewhite matter microstructure measurement

SPIRE2 EPPK1 WDR55 CPED1 CCM2 ARHGAP21 ARMC9 HAPLN1 CACNA2D3

6.65e-033902529EFO_0005674
Diseasesmoking status measurement, chronic obstructive pulmonary disease

ASAP2 EEFSEC GYPA ZKSCAN4

6.92e-03882524EFO_0000341, EFO_0006527
DiseaseProfound Mental Retardation

PARP1 NDST1 RALGDS SHANK3 ZNF526

6.95e-031392525C0020796
DiseaseMental Retardation, Psychosocial

PARP1 NDST1 RALGDS SHANK3 ZNF526

6.95e-031392525C0025363
DiseaseMental deficiency

PARP1 NDST1 RALGDS SHANK3 ZNF526

6.95e-031392525C0917816
Diseaseamyotrophic lateral sclerosis, age at onset

ANKS1B KDM4A

7.09e-03152522EFO_0004847, MONDO_0004976
DiseaseAutosomal recessive primary microcephaly

ZNF335 CDK5RAP2

7.09e-03152522cv:C3711387
Diseaseglycerate measurement

PAIP2 HMCN1

7.09e-03152522EFO_0021029
Diseaseresponse to olanzapine

HIVEP1 ANKS1B

7.09e-03152522GO_0097333
DiseaseUnipolar Depression

ACE NTRK3 GRM7 SLC6A2 ARSA DIXDC1 PCNT

7.10e-032592527C0041696
Diseaseneuropsychological test

FBXO40 SP100 TOX FER1L6 AEBP2 BCL11B

7.11e-031972526EFO_0003926
Diseasenevus count, cutaneous melanoma

PARP1 HERC2 MIA3 DTNB

7.77e-03912524EFO_0000389, EFO_0004632
Diseaseendoplasmic reticulum resident protein 29 measurement

EGFL7 TNXB

8.06e-03162522EFO_0020346
DiseasePre-Eclampsia

ACE CP

8.06e-03162522C0032914
Diseasecathepsin L1 measurement

LRRK2 ADGB

8.06e-03162522EFO_0010619
DiseaseBipolar Disorder

ABCA13 TRPC3 ACE TRPC7 SYNE1 NTRK1 GRM7 SLC6A2 DIXDC1 PCNT

8.29e-0347725210C0005586
DiseaseNeurodevelopmental Disorders

TANC2 SETD2 PPP2R5D CACNA2D3

8.38e-03932524C1535926
Diseaseocular hypertension, response to triamcinolone acetonide

PALMD TRIM38 CHD9

8.49e-03492523EFO_0006954, EFO_1001069

Protein segments in the cluster

PeptideGeneStartEntry
HVLAVQGTITDLPDH

UMAD1

96

C9J7I0
LHAANVVLDQDTGHP

BTN2A3P

296

Q96KV6
SLGDTIGEHHPTREL

ALS2CL

171

Q60I27
STLGPQALELEHCHE

LINC01547

101

P58512
ELIAIDPHAAHGSEV

ERICH6

321

Q7L0X2
GHPADHELLRQELNT

FBRSL1

401

Q9HCM7
PDLADHIRSIHVDGQ

AEBP2

276

Q6ZN18
QTLGFEITIEHPHTD

CCNT2

141

O60583
LHSLASQALEHGLPD

EGFL7

221

Q9UHF1
DTHPDHQDILKAIVA

ARHGEF6

396

Q15052
EAGSEPHIEAHSLEL

ARID4A

816

P29374
ISFDPALIHDNGLIH

CLSTN3

466

Q9BQT9
ITHDEEPGKNLVLEH

CCDC7

781

Q96M83
HLPVDGVHFLTQSEV

CPED1

896

A4D0V7
GDVLALSVSTPEHLH

ACE

421

P12821
ERHEELINLGSPDSH

ADGB

1291

Q8N7X0
TPHRDNLHQIDAVEG

ADO

186

Q96SZ5
HIDTNALHVPRDGAE

ACTL6B

66

O94805
PQTVDHISQEHEGDL

ARFGEF1

251

Q9Y6D6
IDDITLDHLTPLHVA

ANK1

331

P16157
DPQHHTIDSLEQGIS

DIXDC1

531

Q155Q3
HEEHRGAAEELASTP

FAM117A

286

Q9C073
PAHISLLHVEQEVAG

ABCF3

231

Q9NUQ8
PLTADEAHVHLQEEG

ADGRA1

391

Q86SQ6
IQELLHSEHLGPSEL

APLP1

481

P51693
ASILDHFHLSPQGED

ABCA13

1856

Q86UQ4
TEHHNGIAELLEILG

PPP2R5D

291

Q14738
LSGHDDEVFVLEAHP

BRWD3

461

Q6RI45
EHHNGIAELLEILGS

PPP2R5C

216

Q13362
SDNPGLELHHKELEA

ADGRL2

1311

O95490
SEIPITLDHGNTLHE

CAPN13

331

Q6MZZ7
GPELAQHEELTLLFH

ANGPTL8

26

Q6UXH0
LPGHLTQEHDAVLSL

CCM2

101

Q9BSQ5
LEIEDAHGHTPLTLA

ANKRD50

571

Q9ULJ7
VQVLLEHGADPNHAD

ANKRD50

1061

Q9ULJ7
LQTLGFELTIDHPHT

CCNT1

141

O60563
ENEPAGTLILQLHAH

CELSR1

256

Q9NYQ6
AQHHLEGAQSVPLDD

DNHD1

3056

Q96M86
ILLEHGADPNLADVH

ANKRD26

131

Q9UPS8
TGHEDCLELLLEHSP

ANKRD52

801

Q8NB46
EDQPTLEITHHAGKS

ADAMTS10

296

Q9H324
TIPENGIAHHDNAVL

ADAMTS6

341

Q9UKP5
EAISLIIHHDSEPNL

AP2A2

311

O94973
SLLEAVKIGDPHTHE

ATP8B2

471

P98198
TALSAEHRPENLHGV

CDK5RAP2

901

Q96SN8
GDVDVLITHPDGRSH

POLL

426

Q9UGP5
PEHNLTHPELSVAVE

IQGAP1

441

P46940
EAHPEATDALGHLLN

MTUS2

351

Q5JR59
DQPLVEANHLLHESD

RCN3

276

Q96D15
DLEPILEASVLSSHH

ADIPOR2

41

Q86V24
PSIINEDVIINGHSH

PAIP2

11

Q9BPZ3
AVHHLVLVASDGGDP

PCDHGA2

206

Q9Y5H1
IHGEQLDPHVTAFNL

OSMR

186

Q99650
HGLETAHSELPQQDS

RAB44

701

Q7Z6P3
HLPSVAHLEDFQGLT

RIMBP3B

1536

A6NNM3
ENHDPVGSILIQIHE

IQCH

6

Q86VS3
LLLDIHTHEAGTGQA

INTS8

616

Q75QN2
VALPHSGALDRHQDS

IRX4

416

P78413
EHPLADHVSHLENVS

KAT2A

151

Q92830
LHQQHIGLSPAEAEF

PTPN4

191

P29074
AAVDPDSGLEHSAHV

PARP1

531

P09874
IHPGDHSEVLEQLGL

NPAS1

186

Q99742
EDVDHLRPHGVLDNT

KIAA0895L

421

Q68EN5
HLPVLEELDLSHNAL

LRRC3C

101

A6NJW4
LQVLDQHPVGTSDHR

MICA

346

Q29983
VVAEPTLLGQDHILH

OOSP3

36

A0A2R8YFM6
ELSSGPTAEALHHSL

RDM1

21

Q8NG50
EEEHLGILGPQLHAD

CP

801

P00450
EEGLEELHASHIPTA

CD6

526

P30203
HTGQEPSERHTEEAL

ANKS1B

1231

Q7Z6G8
LKEQEESLGSPVHHS

PALMD

506

Q9NP74
RKLEVDSHSLHGPVN

REST

521

Q13127
LDSLHHLPGAENLTE

NTRK1

56

P04629
LADASFHGPEHVVEQ

KIAA0100

976

Q14667
EHPQTAEEGESSLTH

LRRC37A3

501

O60309
AELHIQDALPEDHGT

MYLK

566

Q15746
SPDHTQGEDILDAVH

LRRTM2

341

O43300
NSEEFLDLPVDTLHH

KLHL6

206

Q8WZ60
HSGRSHLEPEEKQAL

HIRIP3

36

Q9BW71
DLLDNTDIHLHFPAG

LONP2

721

Q86WA8
EHPQTAEEGESSLTH

LRRC37A2

501

A6NM11
EHPQTAEEGESSLTH

LRRC37A

501

A6NMS7
DHTPVHLALLDEIST

NELFCD

446

Q8IXH7
PAIESHIHRIEGLSQ

GNPTAB

386

Q3T906
ISGEEDSASPLHHIN

NTRK3

471

Q16288
LEESEHLPLSTVHTE

NPY4R

346

P50391
HAAISHQVDPEFLGL

HERC2

841

O95714
DFPRGHVEELSISHQ

DST

3466

Q03001
ATHHITNEGVAASLP

HMCN2

981

Q8NDA2
IPLANGHEPDETALH

ASAP2

576

O43150
GHEPDETALHLAVRS

ASAP2

581

O43150
VLSDLLGHENHEIQP

ARMC9

506

Q7Z3E5
TALHLAVHLDQPGAV

NFKBIE

296

O00221
HDLESIRPAGLHNSA

HPS4

331

Q9NQG7
EQLEDHPGHSSQAPI

HPS4

441

Q9NQG7
SSEVNEESGDLHLPH

LBHD1

91

Q9BQE6
TVAVHSHEPLLSDGA

ARNTL2

581

Q8WYA1
SLIEQEAAHEPTHHE

BPIFA3

226

Q9BQP9
NEGHATILSQDLDPH

NHSL1

476

Q5SYE7
IFESHHERGNPELEQ

MCF2L2

596

Q86YR7
VINGHLLVGLSHEEA

PDZD2

386

O15018
LIAAATHDLDHPGVN

PDE7A

246

Q13946
HEEASVLPLLHAGFN

PDE8B

221

O95263
EGSSHLTPNEVSVHE

NEMP1

391

O14524
QSDLLLPHIHGEDQE

FGD5

191

Q6ZNL6
PVVHETHDLIVDLGD

PEG10

411

Q86TG7
ALHATVVQDLGLHDG

NDST1

261

P52848
HHPLVLQECVSDDET

KDM4A

606

O75164
EIAHGSLAPDAEPHQ

LAGE3

76

Q14657
RHSNSLGPIFDHEDL

LRRK2

931

Q5S007
ENELPHAVHFLNESG

LRRK2

1566

Q5S007
PENSLLEETLHFDHA

MPHOSPH10

396

O00566
GHAEIVQILLNHPET

KRIT1

366

O00522
RAKSHPEVSIEHLGQ

MUC5AC

2166

P98088
HIAPGVTHELASSLD

ARSA

321

P15289
PEAQALLEISGHSRH

MEAK7

431

Q6P9B6
DALDNSHPIEVSVGH

NPEPPSL1

411

A6NEC2
VDLTVHQLEQPHGTL

HSPA12B

326

Q96MM6
IQFLHQDSPSLIHGD

IRAK1

326

P51617
GPSHELLKVNEHRAE

PPP2R3A

436

Q06190
EALESPLCIQHEGHV

PCNT

606

O95613
SPHVGELSNLTHLEL

LRRC8B

741

Q6P9F7
HQEQLSSVPDLTHGE

MTMR4

846

Q9NYA4
EHHVSNPDGTLSIDQ

HMCN1

1216

Q96RW7
IQLHVHEPPSLEDAG

HMCN1

1911

Q96RW7
DGQPLQEDEAHHIIS

HMCN1

2516

Q96RW7
PPHINGSEEHEEISV

HMCN1

3526

Q96RW7
PAHFDSVNGHSELVI

HMCN1

4301

Q96RW7
PHTVANGHELFEVSE

PIK3C2B

316

O00750
DHDLFLIDPLTGDIH

DCHS2

2821

Q6V1P9
PNIVALEDVHESPSH

PNCK

71

Q6P2M8
SALHLENDAPHLESL

PRG3

16

Q9Y2Y8
DSVLDPNVAHHLGRA

CCDC105

51

Q8IYK2
GVTTHNLEDHTKLPL

GALNS

426

P34059
DIESLHTDGPLHDPV

ADAMTS3

791

O15072
LGAEFEPLHIDSLNH

CHD9

41

Q3L8U1
AHTGLDLTVPQHQEV

HS1BP3

16

Q53T59
HLSQRELITPEADHV

BCL11B

11

Q9C0K0
HPVTAENDFLHSLLG

DOCK2

351

Q92608
GNVTIEEGLHDLEHP

CACNA2D3

631

Q8IZS8
EEGLHDLEHPDVSLA

CACNA2D3

636

Q8IZS8
SVEEGLHDLLHPDLA

CACNA2D4

666

Q7Z3S7
EESTHALIAPDEQSH

FRS3

176

O43559
LELSDPVLDEHHQGD

POLQ

1591

O75417
LGIHSAQHPETQLDL

CEP85

706

Q6P2H3
ETGERVQLAHHFSEP

GYPA

76

P02724
DIPSHLADEHALIAS

DTNB

366

O60941
LSPASHVDVDLTIHG

FOXJ1

336

Q92949
EHSENGAVIDPTLLH

CADPS2

701

Q86UW7
VGESESEHQTPDDHL

EHBP1

621

Q8NDI1
DLTAATPGGLHVELH

FBXO40

446

Q9UH90
AHLLLAQLEHSEPIE

RALGDS

241

Q12967
SPSLHAVLERDEGHL

DAGLA

806

Q9Y4D2
LHETLPEEVGHLSFN

HAUS6

776

Q7Z4H7
GPIVHTDHSDLVLEE

KIRREL2

576

Q6UWL6
NPLHQHEDIAEGAIT

GRM7

321

Q14831
RQALHEVHPISSGLE

CBL

206

P22681
FDDGQVPEHLLHALA

DALRD3

51

Q5D0E6
EELHEQLENLGTHGT

CYP39A1

141

Q9NYL5
HFLPLDELEHSLGES

HYAL1

296

Q12794
EHLTDHGAASPQLEP

EMILIN3

131

Q9NT22
EHVEGQSNLESEPIH

EPS15

541

P42566
LENAPLGHSVIHIQA

CELSR3

661

Q9NYQ7
TDHSLQAHAGPTDLD

CELSR3

2866

Q9NYQ7
LGLHNDHLSSLPFEV

FBXO30

606

Q8TB52
QDDAFVHTPALLAHL

B3GNT8

246

Q7Z7M8
LTDHNHDGTPDSLPV

SLC15A1

106

P46059
DALDNSHPIEVSVGH

NPEPPS

411

P55786
DVELVAHHSLEPGFG

IKZF4

356

Q9H2S9
EHEPPGALTELDLSH

NRROS

371

Q86YC3
GDSHLALPALERDHL

LRRC4B

646

Q9NT99
QSLHPSDGHEVALDT

PRDM4

176

Q9UKN5
LASEPQEVLHIGSAH

PDLIM1

106

O00151
HIQAENGPHLLVEAE

HAPLN1

31

P10915
LHSVAHAQAGELLSP

ONECUT3

11

O60422
AVHHLILTASDGGEP

PCDHGA1

206

Q9Y5H4
HFVLLGISTHPEEQI

OR1Q1

11

Q15612
LHIQDEELASTHPGR

FAM180B

66

Q6P0A1
HPSTKDQHLLLGAEE

MAP4K1

506

Q92918
DLLPLLHEGQGDVAH

FER1L6

531

Q2WGJ9
TILNPHVHVIGEDAA

CAMK2B

601

Q13554
GITPENEHHLVAQRD

SLC6A2

591

P23975
AAAHSALEDVEALHP

RGMB

386

Q6NW40
GEHILDLHSPTHIDA

RIMBP2

261

O15034
DLHSPTHIDAGITDN

RIMBP2

266

O15034
LDPDTAHHELILSED

TRIM38

296

O00635
LAHLADDLGHVVPNS

MRPL50

101

Q8N5N7
EGHGHLVTAELPALT

SIGLEC15

216

Q6ZMC9
SLLHGTHVPSTEEID

SYF2

166

O95926
LSQSLPDHHEELHAE

SYNE1

7696

Q8NF91
HCEHPISGLEVLEAE

SYNE4

91

Q8N205
EPTHLDQRVIGDTHA

MIA3

1081

Q5JRA6
EGLAADGPHLHTLTQ

TGFBR3L

216

H3BV60
KAIGTEHDHVLPLQE

LRRC28

261

Q86X40
DHKLHDVLIAPGTAD

NDUFAF7

316

Q7L592
LDDPLAALDAHVGQH

ABCC6

776

O95255
DVAQHLAVAEEPDLH

RECQL4

651

O94761
DPTADSLHVGHLLAL

YARS2

81

Q9Y2Z4
IHIIDREHSGLSPQD

NCOA1

361

Q15788
SDRPGSGVHVEVHDL

NBEA

1041

Q8NFP9
HILSAIEDISGQIGH

SLC9A3

486

P48764
LLVAEQAVTGHHDPF

EPPK1

356

P58107
LQEVSEPLTATKHHG

PTPN14

621

Q15678
QLDAIRDDLGHHAPS

SHROOM1

816

Q2M3G4
EAVTGLHPNQEAHSL

SCARB1

356

Q8WTV0
HPLTDEHIFQAINAG

TANC2

716

Q9HCD6
PTDETVLVHENGRDH

TECTB

226

Q96PL2
LVHEALEDVTGQHLP

PDGFRL

11

Q15198
VHQGLEGDLLEHISP

POU4F3

111

Q15319
LDDPLSAVDAHVGKH

ABCC12

626

Q96J65
DTFTGLVHSHELPLD

RHBDL1

91

O75783
HDGPEPLSLIDDLHS

MRTFA

831

Q969V6
HPEARGHLSEALTED

RIPOR2

706

Q9Y4F9
DHEIDGSHLPALTKE

SHANK1

2121

Q9Y566
HHPDDSGLLEISAVP

C12orf29

171

Q8N999
HILPAELEEQSNHAG

C12orf76

76

Q8N812
LETDSGLEHSLPHSV

C15orf39

21

Q6ZRI6
DLHPEIHALLQSAEL

SPG11

1926

Q96JI7
HDGDSLSRSQDHIPL

PITPNM1

501

O00562
RPSELEDGHTALNTH

PDCD11

1121

Q14690
PAHETGQGIVHALTD

PHC2

516

Q8IXK0
PESLHTVHAALISVE

EEFSEC

306

P57772
LLVHPSGDHARDAQD

USP42

871

Q9H9J4
FDVHHVESLAEQGTP

ZNF653

246

Q96CK0
HHTEVLPTAQKLADE

ZSWIM5

291

Q9P217
HGQESLSDELQETHP

ZNF691

71

Q5VV52
GHVSAHPDILSLENR

TEP1

6

Q99973
GHVSAHPDILSLENR

TEP1

96

Q99973
GDHIIIDGLHAESPD

MIPEP

246

Q99797
RHPHDIIDDINSGAV

RPL12

146

P30050
DHEIEGAHLPALTKD

SHANK3

1691

Q9BYB0
HDPLELHTIVIDCSA

SLC26A2

641

P50443
HLETPRAELDSLGHT

SPIRE2

226

Q8WWL2
DQHHLDLTALPTPES

SEMA6A

746

Q9H2E6
DEESPEAELHNHGIQ

SP100

271

P23497
AHHLEIDSGVITLDP

TRIM15

286

Q9C019
EPHLGELTVEEATSH

TNXB

1881

P22105
GIHTGPLEDSLFLNH

TEX43

71

Q6ZNM6
EELHALASEPRGQHV

VWA2

191

Q5GFL6
TQLGNHDVDPEISHV

ZSCAN5A

31

Q9BUG6
PRVDLHTSGEHSELV

ZNF281

631

Q9Y2X9
DSFDGSDQILPHHIL

MYCBPAP

131

Q8TBZ2
SDQILPHHILGSLQD

MYCBPAP

136

Q8TBZ2
LEESEHLPLSTVHTE

NPY4R2

346

P0DQD5
TFNHLIPTEHLDDAL

PHF3

6

Q92576
RTIPGHEFLLQSDHE

ARHGAP9

406

Q9BRR9
LVNHTVDAVELEPSH

SUCO

711

Q9UBS9
DDVVLPALHFHQGDS

TBC1D15

156

Q8TC07
QDAISDLESIRHHPD

TTC21A

56

Q8NDW8
VTPLHDALSNGHVEI

SLF1

876

Q9BQI6
CEIPHVDGLHSSEEL

SETD2

1241

Q9BYW2
PTEHADLQGRTALHD

UACA

126

Q9BZF9
HEIHDPQHLETADAS

ZNF644

931

Q9H582
HLREDIAQIPTHAEA

ZKSCAN4

286

Q969J2
GQHTGEPVEELALSH

WDR55

291

Q9H6Y2
PENLHTEEILVCGHS

VPS13B

1711

Q7Z7G8
LILSPGELLAHQDAH

ZNF526

116

Q8TF50
SLDHFDEHGDPLQRQ

SCN11A

506

Q9UI33
RGEHVLHLEPGSVES

SEMA3G

151

Q9NS98
DIKPDNILLDEHGHV

STK32B

146

Q9NY57
NPLAGTEDHSHLQEP

VEGFD

241

O43915
TLDHGLAAEVVHGPD

ZNF711

61

Q9Y462
ADLVTGPNGHLEHVV

ZNF711

131

Q9Y462
DHDIAHIPASAVISA

ARHGAP21

816

Q5T5U3
GTQLHHIELTADGSI

ZNF335

931

Q9H4Z2
LTEHTRLHSGEEPFQ

ZNF425

541

Q6IV72
EPALHEQHQVTGIDD

TRIM62

116

Q9BVG3
HIGDHSSIIENQEFP

ZNF235

161

Q14590
PSLPDHSLVHLNEVE

TOX

76

O94900
SHPHQLALSDALRGE

HIVEP1

1191

P15822
EEELLHHSLTAHGAP

ZNF219

201

Q9P2Y4
HPSHEQIILLLEGES

ZFYVE16

1041

Q7Z3T8
NGDLESAEPLEVHRH

TRPC3

276

Q13507
LLDADIHSAHPSVII

UBR5

251

O95071
RSHNDEHSDVLPVLD

UBR5

1926

O95071
SADVDIHHLASLDPE

UBE3C

851

Q15386
HVQDDTLHNVSLPPE

TRPC7

506

Q9HCX4
LPEDAGIDHQTVHQL

UNC79

1266

Q9P2D8
HHTEVLPTAQRLADE

ZSWIM4

211

Q9H7M6
QLTLEHDPHDTLGHG

LIMK1

251

P53667